YaFarm Technologies Announces Funding for ISCI
2013年3月6日 - 9:30PM
Marketwired
YaFarm Technologies, Inc. (PINKSHEETS: YFRM) (YaFarm, or the
Company) announced today that the Integrative Stem Cell Institute
(ISCI) has received significant funding for its venture in Cancun,
Mexico.
The ISCI is a premier provider of cell-based, regenerative
medical therapies that utilize a patient's own stem cells for the
treatment of neuro-degenerative diseases. Combining a
state-of-the-art laboratory and clean room facility with an
integrative medical approach to treatment, the ISCI provides
therapies as part of controlled clinical studies. The ISCI has
partnered with the International Stem Cell Practice (ISCP) to
provide patients with access to a global network of physicians to
provide pre-treatment evaluation and post-therapy follow up for the
independent collection and evaluation of patient outcomes.
The investment will be used to complete the construction of the
new medical facility housed within Hospital Galenia in Cancun,
Mexico. The hospital is accredited by both the Joint Commission
(JCI) and the Accreditation Canada (ACI), and is the only hospital
in Mexico to have been awarded certification from both of these
organizations.
"The funding is important," says David Audley, CEO of the ISCI.
"The pace of work for both the laboratory facility and the clean
room space is moving fast, and this final infusion of capital will
allow us to complete the project earlier than scheduled." Once
finished, the ISCI will be able to initiate the clinical studies
for diseases such as Parkinson's, Alzheimer's and Multiple
Sclerosis.
"This last stage financing allows us to deliver these therapies
to patients sooner than we expected," continues Mr Audley. "With a
state-of-the-art lab, a world-class medical facility and a truly
integrative treatment approach represent the next great stage of
cell-based medicine, and patient care."
About Integrative Stem Cell Institute
(ISCI)
The Integrative Stem Cell Institute (ISCI) is a premier provider
of point-of-care, stem cell-based therapies for patients from
around the world. With a state of the art laboratory housed within
the Hospital Galenia in Cancun, Mexico, the ISCI combines the most
advanced scientific application of stem cells with second to none
medical care within the structure of adaptive clinical trials to
effectively track long term outcomes and assure patient safety.
More information on the Integrative Stem Cell Institute is
available at www.iscelli.com
SAFE HARBOR STATEMENT
This press release may contain certain forward-looking
statements and information, as defined within the meaning of
Section 27A of the Securities Act of 1933 and Section 21E of the
Securities Exchange Act of 1934, and is subject to the Safe Harbor
created by those sections. Forward-looking statements are
inherently subject to risks and uncertainties, some of which cannot
be predicted or quantified. This material contains statements about
expected future events and/or financial results that are
forward-looking in nature and subject to risks and uncertainties.
Future events and actual results could differ materially from those
set forth in, contemplated by, or underlying the forward-looking
statements. The risks and uncertainties to which forward looking
statements are subject include, but are not limited to, the effect
of government regulation, competition, adequate financing, and
other material risks. Such forward-looking statements by definition
involve risks, uncertainties and other factors, which may cause the
actual results, performance, or achievements to be materially
different from the statements made herein.
Contact: The Integrative Stem Cell Institute Contact: Miranda
Abrahams Miranda@iscelli.com Investor Contact Atlanta Capital
Partners, LLC David Kugelman (866) 692-6847 info@atlcp.com
Profile Solutions (CE) (USOTC:PSIQ)
過去 株価チャート
から 5 2024 まで 6 2024
Profile Solutions (CE) (USOTC:PSIQ)
過去 株価チャート
から 6 2023 まで 6 2024